Why patients don't take part in cancer clinical trials: an overview of the literature

被引:82
作者
Cox, K [1 ]
McGarry, J [1 ]
机构
[1] Univ Nottingham, Sch Med, Fac Med & Hlth Sci, Sch Nursing, Nottingham, England
关键词
cancer clinical trials; non-participation; literature review;
D O I
10.1046/j.1365-2354.2003.00396.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clinical trials have been recognized extensively within the literature as a crucial component in the research, development and evaluation of treatment strategies within health care services. However, it has also been acknowledged that clinicians and researchers have historically experienced problems in terms of attaining adequate recruitment to clinical trials. The purpose of this review is to explore some of these questions and, more importantly, provide possible explanations for non-participation in clinical trials, with specific reference to the field of cancer research. In addition, approaches that have been used by researchers in order to explore the issue of non-participation, and suggestions in terms of the ways that further research into this key area may be undertaken, are also be considered.
引用
收藏
页码:114 / 122
页数:9
相关论文
共 48 条
[31]   Evaluating minority recruitment into clinical studies: How good are the data? [J].
Ness, RB ;
Nelson, DB ;
Kumanyika, SK ;
Grisso, JA .
ANNALS OF EPIDEMIOLOGY, 1997, 7 (07) :472-478
[32]   INFORMED CONSENT FOR INVESTIGATIONAL CHEMOTHERAPY - PATIENTS AND PHYSICIANS PERCEPTIONS [J].
PENMAN, DT ;
HOLLAND, JC ;
BAHNA, GF ;
MORROW, G ;
SCHMALE, AH ;
DEROGATIS, LR ;
CARNRIKE, CL ;
CHERRY, R .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (07) :849-855
[33]   Participants strengthen clinical trial research: The vital role of participant advisors in the breast cancer prevention trial [J].
Psillidis, L ;
Flach, J ;
Padberg, RM .
JOURNAL OF WOMENS HEALTH, 1997, 6 (02) :227-232
[34]   Recruitment for complementary/alternative medicine trials: Who participates after breast cancer [J].
Richardson, MA ;
Post-White, J ;
Singletary, SE ;
Justice, B .
ANNALS OF BEHAVIORAL MEDICINE, 1998, 20 (03) :190-198
[35]  
ROBERSON NL, 1994, CANCER, V74, P2687, DOI 10.1002/1097-0142(19941101)74:9+<2687::AID-CNCR2820741817>3.0.CO
[36]  
2-B
[37]   Attitudes of African-Americans regarding prostate cancer clinical trials [J].
Robinson, SB ;
Ashley, M ;
Haynes, MA .
JOURNAL OF COMMUNITY HEALTH, 1996, 21 (02) :77-87
[38]   PATIENT MOTIVATION AND INFORMED CONSENT IN A PHASE-I STUDY OF AN ANTICANCER AGENT [J].
RODENHUIS, S ;
VANDENHEUVEL, WJA ;
ANNYAS, AA ;
KOOPS, HS ;
SLEIJFER, DT ;
MULDER, NH .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (04) :457-462
[39]   REASONS FOR ENTRY INTO AND UNDERSTANDING OF HIV AIDS CLINICAL-TRIALS - A PRELIMINARY-STUDY [J].
ROSS, MW ;
JEFFORDS, K ;
GOLD, J .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 1994, 6 (01) :77-82
[40]   APPROPRIATE CHEMOTHERAPY FOR PALLIATING ADVANCED CANCER [J].
RUBENS, RD ;
TOWLSON, KE ;
RAMIREZ, AJ ;
COLTART, S ;
SLEVIN, ML ;
TERRELL, C ;
TIMOTHY, AR .
BRITISH MEDICAL JOURNAL, 1992, 304 (6818) :35-40